1992
DOI: 10.1016/0016-5085(92)90109-c
|View full text |Cite
|
Sign up to set email alerts
|

Hepatocellular transplantation into the lung for temporary support of acute liver failure in the rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
5
0

Year Published

1995
1995
2011
2011

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(5 citation statements)
references
References 18 publications
0
5
0
Order By: Relevance
“…Activated endothelial cells in turn would release adhesion molecules, facilitating hepatocyte anchorage. Moreover, induction of xanthine oxidase-mediated release of reactive oxygen species and superoxide radical production could lead to endothelial injury, paving the way for transplanted cells to enter the liver plate after approximately 16 to 20 hours of transplantation. Endothelial disruption is facilitated by the release of vascular endothelial growth factor (VEGFIVPF) from transplanted as well as host hepatocytes prior to the entry of cells into liver plates.…”
Section: Mechanisms Of Cell Engraftment and Proliferation In The Disementioning
confidence: 99%
“…Activated endothelial cells in turn would release adhesion molecules, facilitating hepatocyte anchorage. Moreover, induction of xanthine oxidase-mediated release of reactive oxygen species and superoxide radical production could lead to endothelial injury, paving the way for transplanted cells to enter the liver plate after approximately 16 to 20 hours of transplantation. Endothelial disruption is facilitated by the release of vascular endothelial growth factor (VEGFIVPF) from transplanted as well as host hepatocytes prior to the entry of cells into liver plates.…”
Section: Mechanisms Of Cell Engraftment and Proliferation In The Disementioning
confidence: 99%
“…Among these procedures is the transplantation of isolated hepatocytes to various systemic sites. Numerous sites have been examined, including fat pads, muscle, subcutaneous tissue, peritoneum, lungs, kidney, liver, and spleen (Balladur et al 1994; Fuller 1988; Rivas et al 1992; Sandbichler et al 1992; Selden et al 1991). In spite of the disadvantages of the intrasplenic site, such as the need for syngeneic hepatocytes, which would otherwise require immunosuppressive therapy, and its size limitation, which allows the spleen to accommodate hepatic tissue amounting to only about 3–4% of normal liver weight, the spleen has been shown to be a highly effective site, at least in experimental animals (Dixit 1995).…”
Section: Introductionmentioning
confidence: 99%
“…Nonetheless, in animals with liver failure induced by 90% hepatectomy, transplantation of microcarrier‐attached hepatocytes into the peritoneal cavity, subsequent to the onset of liver failure, did not alter survival21, although others showed that transplantation of microencapsulated hepatocytes improved survival16, 22–24. Transplantation of hepatocytes into lungs has also been reported to improve survival in acute liver failure25. However, the survival of hepatocytes in pulmonary capillaries is extremely limited and transplanted cells are cleared rapidly26, suggesting the possibility of alternative mechanisms.…”
Section: Introductionmentioning
confidence: 99%